1.06

8.16% +0.08

Pre-market: 1.10 0.04 +3.77%

INVO Bioscience Inc (INVO)

Overview News Price History Why INVO Down? Discussions Forecast Stock Split

INVO Bioscience Inc stock is currently priced at $1.06, with a 24-hour trading volume of 315.24K. It has seen a +8.16% increased in the last 24 hours and a -6.19% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.9927 pivot point. If it approaches the $1.08 resistance level, significant changes may occur.

Previous Close:

$0.98

Open:

$1.03

24h Volume:

315.24K

Market Cap:

$2.91M

Revenue:

$1.92M

Net Income/Loss:

$-8.81M

P/E Ratio:

-0.0668

EPS:

-15.86

Net Cash Flow:

$-5.41M

1W Performance:

-14.52%

1M Performance:

-6.19%

6M Performance:

-18.46%

1Y Performance:

+194.36%

1D Range:

$1.03

$1.0981

52W Range:

$0.123

$7.1999

INVO Bioscience Inc Stock (INVO) Company Profile

Name

INVO Bioscience Inc

Sector

Healthcare (1191)

Industry

Medical Devices (158)

Phone

978 878 9505

Address

5582 Broadcast Court, Sarasota

Employee

Twitter

Next Earnings Date

2024-05-13

Latest SEC Filings

INVO's Discussions on Twitter

INVO Bioscience Inc Stock (INVO) Latest News

These Are the Top Reasons to Trade Penny Stocks in 2024

PennyStocks

Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views

Benzinga

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge

Benzinga

Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings

Benzinga

Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket

Benzinga

INVO Bioscience Inc Stock (INVO) Financials Data

INVO Bioscience Inc (INVO) Revenue 2024

INVO reported a revenue (TTM) of $1.92 million for the quarter ending September 30, 2023, a -46.64% decline year-over-year.

INVO Bioscience Inc (INVO) Net Income 2024

INVO net income (TTM) was -$8.81 million for the quarter ending September 30, 2023, a -6.53% decrease year-over-year.

INVO Bioscience Inc (INVO) Cash Flow 2024

INVO recorded a free cash flow (TTM) of -$5.41 million for the quarter ending September 30, 2023, a +20.33% increase year-over-year.

INVO Bioscience Inc (INVO) Earnings per Share 2024

INVO earnings per share (TTM) was -$12.34 for the quarter ending September 30, 2023, a +3.67% growth year-over-year.

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.